Tiziana Life Sciences closes $8.8 million direct offering of 7,040,000 ordinary shares at $1.25 each, with potential $10.56 million additional gross proceeds from warrants.

On January 16, 2026, Tiziana Life Sciences, Ltd. announced the completion of a registered direct offering of 7,040,000 ordinary shares at a rate of $1.25 per share. The total gross proceeds amounted to $8.8 million, after accounting for estimated offering expenses. The offering was conducted without an underwriter or placement agent, exclusively for senior management and existing shareholders. Furthermore, participants in the offering will receive one warrant for each ordinary share purchased, allowing them to subscribe for an additional ordinary share at a price of $1.50 until July 16, 2026. This may potentially generate extra gross proceeds of around $10.56 million.